Results for tag: "Anti Dickkopf"

The Anti-Dickkopf (DKK) market is a subset of the larger Immune Disorders Drugs market. It is focused on the development of drugs that target the DKK family of proteins, which are involved in the regulation of the immune system. These drugs are used to treat a variety of immune-related disorders, such as autoimmune diseases, allergies, and inflammatory conditions. The Anti-Dickkopf market is a rapidly growing field, with a number of companies investing in research and development of new drugs. These companies are focused on developing treatments that target the DKK family of proteins, as well as other immune-related targets. Some of the companies in the Anti-Dickkopf market include AbbVie, Amgen, AstraZeneca, Biogen, Celgene, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. These companies are actively researching and developing new drugs to treat immune-related disorders. Show Less Read more